Results
2534
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,534 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$915.04 | -2.1% | 66.3% | US$814.9b | US$995.42 | PE112.2x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$577.07 | -1.9% | 15.2% | US$536.2b | US$622.65 | PE37.8x | E23.4% | 1.5% | Healthcare | ||
JNJ | US$164.82 | 0.1% | 2.0% | US$400.0b | US$171.32 | PE24.2x | E7.2% | 3.0% | Pharmaceuticals & Biotech | ||
ABBV | US$193.62 | -0.2% | 26.2% | US$340.8b | US$196.30 | PE64.6x | E25.4% | 3.2% | Pharmaceuticals & Biotech | ||
MRK | US$117.23 | 1.7% | 9.8% | US$300.7b | US$139.03 | PE21.6x | E14.4% | 2.6% | Pharmaceuticals & Biotech | ||
AZN | UK£118.98 | -1.3% | 9.3% | UK£184.5b | UK£138.27 | PE38x | E16.4% | 1.9% | Pharmaceuticals & Biotech | ||
TMO | US$620.25 | 1.0% | 23.7% | US$233.1b | US$643.36 | PE38.1x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
ABT | US$114.15 | -2.3% | 15.4% | US$199.9b | US$124.12 | PE35.9x | E11.7% | 1.9% | Healthcare | ||
DHR | US$276.43 | 1.4% | 10.7% | US$196.4b | US$288.05 | PE49.2x | E14.3% | 0.4% | Pharmaceuticals & Biotech | ||
AMGN | US$335.95 | 1.8% | 24.7% | US$178.9b | US$325.55 | PE57.7x | E23.8% | 2.7% | Pharmaceuticals & Biotech | ||
ISRG | US$490.01 | -0.8% | 72.3% | US$171.3b | US$483.95 | PE83.2x | E12.5% | n/a | Healthcare | ||
PFE | US$29.66 | 1.7% | -9.7% | US$168.6b | US$33.61 | PS3x | E32.9% | 5.7% | Pharmaceuticals & Biotech | ||
SYK | US$365.05 | -0.7% | 28.3% | US$137.7b | US$372.59 | PE40.3x | E10.8% | 0.9% | Healthcare | ||
ELV | US$538.00 | -1.4% | 19.3% | US$125.1b | US$603.07 | PE18.6x | E11.6% | 1.2% | Healthcare | ||
REGN | US$1,150.19 | -1.2% | 39.7% | US$122.9b | US$1,162.19 | PE28.7x | E10.5% | n/a | Pharmaceuticals & Biotech | ||
VRTX | US$477.90 | -0.2% | 34.9% | US$122.4b | US$509.82 | PS11.9x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
BSX | US$83.71 | -0.1% | 55.1% | US$121.6b | US$87.26 | PE67.4x | E20.9% | n/a | Healthcare | ||
MDT | US$89.47 | -0.6% | 11.2% | US$113.0b | US$94.62 | PE29.2x | E11.2% | 3.1% | Healthcare | ||
GILD | US$83.90 | 0.9% | 11.5% | US$104.4b | US$83.54 | PE99.1x | E36.0% | 3.7% | Pharmaceuticals & Biotech | ||
HCA | US$403.52 | 3.0% | 59.2% | US$103.2b | US$396.60 | PE18.1x | E6.3% | 0.7% | Healthcare | ||
BMY | US$49.02 | 1.6% | -17.0% | US$100.8b | US$53.34 | PS2.1x | E49.0% | 4.9% | Pharmaceuticals & Biotech | ||
CI | US$357.26 | -1.4% | 22.8% | US$99.3b | US$398.29 | PE26.9x | E19.4% | 1.6% | Healthcare | ||
CSL | AU$293.64 | -2.2% | 16.5% | AU$142.2b | AU$309.80 | PE36.7x | E12.9% | 1.3% | Pharmaceuticals & Biotech | ||
ZTS | US$193.24 | 1.3% | 9.4% | US$89.0b | US$213.12 | PE37.3x | E10.2% | 0.9% | Pharmaceuticals & Biotech |